TIB Molbiol: TIB Molbiol develops test kits for Omicron variant detection

TIB Molbiol, a newly acquired subsidiary of Roche, has developed three new VirSNiP test kits for the detection of mutations in the recently-discovered Omicron variant of COVID-19. The three new Research Use Only (RUO) test kits are intended to help differentiate unique mutations of Omicron from other COVID-19 variants. read more